Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Omnicom Group OMC Delivers Q1 2026 Beat EPS 190 vs 187 Expected Financial Sector AI Investment Surged in 2025 Reshaping Competitive Landscape Sangoma SANG Q1 2026 Earnings Miss by Significant Key Takeaways CNB Fin Corp CCNEP Crushes Q1 2026 Estimates EPS 088 Tops Views India Adjusts Fuel Prices Modestly After 76Day Freeze Amid Middle East Tensions UK Student Loans Inquiry Draws Over 52000 Responses Highlighting Massive Scale of Frustration and Upset Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum Goldman Sachs CEO David Solomon AIDriven Job Loss Fears Overblown May Create New Opportunities April Retail Sales Meet Expectations as Consumer Spending Remains Modest US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate Data Shows Diamond Hill Investment Group Q1 2025 Earnings Steady EPS Amid Quiet Market Response KTB Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher GRRR Q4 2025 Earnings EPS Misses Estimates Sharply Yet Stock Surges TBN Q1 2026 Earnings EPS Miss Reflects Exploration Costs and No Revenue Generation ClearPoint Neuro Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement DuPont DD Q1 2026 Earnings EPS Beat Surprises Stock Rises 2 Clearway Energy CWEN Edges Higher as Renewable Sector Shows Stability Key Levels to Watch AGNC Preferred Stock AGNCZ Holds Steady Near 2535 Amid Steady Trading BioNexus Gene Lab Corp BGLC Surges 844 Testing Key Resistance at 230 U Power Limited UCAR Tests Support After 33 Decline Key Levels in Focus NexGel Inc NXGL Shows Modest Gains Trading Near Support Levels PSQH Q1 2026 Earnings Narrower Loss Beats Estimates as Stock Declines CNTA Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Flat Curbline Properties Q1 2026 Earnings Miss on EPS Stock Edges Higher RLJ Lodging Trust Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Discipline Supports Results Saratoga Investment Corp 750 Notes due 2031 SAV Q1 2026 Earnings Substantial EPS Miss Weighs on Investor Sentiment BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide